Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 50
Filtrar
Más filtros

Medicinas Complementárias
Tipo del documento
Intervalo de año de publicación
1.
J Emerg Med ; 58(3): e129-e132, 2020 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-31806433

RESUMEN

BACKGROUND: One Health is a biomedical approach that aims to optimize the health of humans, animals, and the environment through interdisciplinary collaboration. Cellulitis is an infection of the dermis and subcutaneous fat that may be caused by zoonotic streptococci species. CASE REPORT: We report a case of cellulitis caused by Streptococcus canis in a woman who was taking Etanercept. We frame the presentation within a One Health approach and urge emergency physicians to collaborate with veterinarians in the management of patients with zoonotic diseases who are discharged home. WHY SHOULD AN EMERGENCY PHYSICIAN BE AWARE OF THIS?: Pets are a source for zoonotic diseases, including resistant bacteria, that pose particular risk to immunocompromised patients. Emergency physicians often discharge patients with potential zoonotic infections such as cellulitis home without a long-term, holistic care plan, according to a One Health approach. Physicians should then collaborate with veterinarians in caring for humans and animals.


Asunto(s)
Bacteriemia , Celulitis (Flemón) , Etanercept , Huésped Inmunocomprometido , Infecciones Estreptocócicas , Animales , Bacteriemia/tratamiento farmacológico , Celulitis (Flemón)/tratamiento farmacológico , Celulitis (Flemón)/microbiología , Servicio de Urgencia en Hospital , Etanercept/efectos adversos , Femenino , Humanos , Salud Única , Infecciones Estreptocócicas/tratamiento farmacológico , Streptococcus
3.
J Korean Med Sci ; 33(24): e164, 2018 Jun 11.
Artículo en Inglés | MEDLINE | ID: mdl-29892207

RESUMEN

BACKGROUND: We investigated the clinical progress and bacteriological characteristics of infectious adverse events (AEs) following acupuncture and compared patient characteristics between serious and non-serious outcome groups. METHODS: A retrospective observational study was conducted in 1,174 patients with infectious complications associated with acupuncture at the emergency department (ED) in a tertiary hospital in Korea between 2010 and 2014. Serious outcome was defined as development of septic shock, admission to intensive care unit (ICU) or attaining permanent morbidity. RESULTS: Forty-eight patients had certain causality and cellulitis, necrotizing fasciitis and osteomyelitis were common in order. Among them, 9 patients (18.8%) were categorized into serious outcome group, and they showed devastating outcomes such as septic shock (n = 2), ICU admission (n = 4), and permanent sequelae (n = 5). The serious group had delayed admission to the ED after acupuncture (30.0 [4.0-55.0] vs. 3.0 [1.0-10.0] days, P = 0.023). Methicillin-sensitive Staphylococcus aureus was the most frequently identified microorganism. The patients in the serious group required longer treatment duration (139.0 [49.0-183.5] vs. 14.0 [7.0-34.0] days, P < 0.001) as well as more operation with local (44.4% vs. 10.3%, P = 0.031) or general anaesthesia (33.3% vs. 2.6%, P = 0.017). CONCLUSION: The infectious AEs after acupuncture may cause serious outcomes. Patients and primary physicians should be aware of the risk of infectious complications and make efforts to prevent them.


Asunto(s)
Terapia por Acupuntura/efectos adversos , Celulitis (Flemón)/etiología , Fascitis Necrotizante/etiología , Osteomielitis/etiología , Choque Séptico/etiología , Anciano , Bacterias/aislamiento & purificación , Celulitis (Flemón)/microbiología , Servicio de Urgencia en Hospital , Fascitis Necrotizante/microbiología , Femenino , Humanos , Unidades de Cuidados Intensivos , Tiempo de Internación , Masculino , Persona de Mediana Edad , Osteomielitis/microbiología , Estudios Retrospectivos , Choque Séptico/microbiología , Staphylococcus aureus/aislamiento & purificación , Centros de Atención Terciaria
4.
Transpl Infect Dis ; 19(1)2017 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-27775824

RESUMEN

Nontuberculous mycobacterial infections can often occur in individuals with adequate immune function. Such infections typically have cutaneous involvement and are caused by rapidly growing mycobacterium. Other nontuberculous mycobacteria species, like Mycobacterium haemophilum, almost always present as opportunistic infections occurring in severely immunocompromised hosts. Here, we present a complicated and protracted course of diagnosing M. haemophilum lower extremity cutaneous infection in a matched-unrelated donor stem cell transplant recipient.


Asunto(s)
Antibacterianos/uso terapéutico , Celulitis (Flemón)/tratamiento farmacológico , Trasplante de Células Madre Hematopoyéticas/efectos adversos , Leucemia Mieloide Aguda/cirugía , Infecciones por Mycobacterium no Tuberculosas/tratamiento farmacológico , Mycobacterium haemophilum/aislamiento & purificación , Infecciones Oportunistas/tratamiento farmacológico , Biopsia , Celulitis (Flemón)/complicaciones , Celulitis (Flemón)/diagnóstico , Celulitis (Flemón)/microbiología , Ciprofloxacina/uso terapéutico , Claritromicina/uso terapéutico , Femenino , Enfermedad Injerto contra Huésped/diagnóstico , Enfermedad Injerto contra Huésped/tratamiento farmacológico , Humanos , Huésped Inmunocomprometido , Terapia de Inmunosupresión/efectos adversos , Inmunosupresores/efectos adversos , Inmunosupresores/uso terapéutico , Extremidad Inferior , Persona de Mediana Edad , Infecciones por Mycobacterium no Tuberculosas/complicaciones , Infecciones por Mycobacterium no Tuberculosas/diagnóstico , Infecciones por Mycobacterium no Tuberculosas/microbiología , Infecciones Oportunistas/complicaciones , Infecciones Oportunistas/diagnóstico , Infecciones Oportunistas/microbiología , Rifabutina/uso terapéutico , Tacrolimus/efectos adversos , Tacrolimus/uso terapéutico , Donante no Emparentado
6.
Intern Med ; 55(9): 1203-5, 2016.
Artículo en Inglés | MEDLINE | ID: mdl-27150881

RESUMEN

Corynebacterium striatum has been described as a pathogen in immunocompromised patients; however, correctly identifying Corynebacterium spp. is often difficult, and cases of cellulitis caused by C. striatum are only rarely reported. We herein describe a case of cellulitis and bacteremia due to C. striatum identified by matrix-assisted laser desorption ionization-time of flight mass spectrometry. Antimicrobial susceptibility testing was performed using the Strepto-Haemo Supplement method, and vancomycin was replaced by a narrow-spectrum oral amoxicillin.


Asunto(s)
Bacteriemia/microbiología , Celulitis (Flemón)/microbiología , Infecciones por Corynebacterium/diagnóstico , Espectrometría de Masa por Láser de Matriz Asistida de Ionización Desorción/métodos , Amoxicilina/uso terapéutico , Antibacterianos/uso terapéutico , Bacteriemia/tratamiento farmacológico , Celulitis (Flemón)/tratamiento farmacológico , Infecciones por Corynebacterium/tratamiento farmacológico , Infecciones por Corynebacterium/microbiología , Femenino , Humanos , Persona de Mediana Edad , Vancomicina/uso terapéutico
7.
J Infect Chemother ; 22(10): 704-6, 2016 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-27040158

RESUMEN

This is the first report of penicillin/cephalosporin-resistant Helicobacter cinaedi arising from prolonged treatment. H. cinaedi, common among immunocompromised patients, caused recurrent bacteremia and cellulitis in a 19-year-old Japanese man with X-linked agammaglobulinemia. The minimal inhibitory concentration of these drugs was raised, which subsequently resulted in clinical failure. Prolonged suboptimal treatment may cause bacterial resistance to ß-lactam antibiotics in H. cinaedi. It is possible that this resistance may have contributed to the treatment failure.


Asunto(s)
Agammaglobulinemia/tratamiento farmacológico , Bacteriemia/microbiología , Celulitis (Flemón)/microbiología , Resistencia a las Cefalosporinas , Enfermedades Genéticas Ligadas al Cromosoma X/tratamiento farmacológico , Infecciones por Helicobacter/microbiología , Helicobacter/aislamiento & purificación , Inmunoglobulinas/efectos adversos , Resistencia a las Penicilinas , Adulto , Amoxicilina/administración & dosificación , Amoxicilina/efectos adversos , Amoxicilina/uso terapéutico , Antibacterianos/administración & dosificación , Antibacterianos/efectos adversos , Antibacterianos/uso terapéutico , Bacteriemia/tratamiento farmacológico , Bacteriemia/inmunología , Celulitis (Flemón)/tratamiento farmacológico , Celulitis (Flemón)/inmunología , Cefalosporinas/administración & dosificación , Cefalosporinas/efectos adversos , Cefalosporinas/uso terapéutico , Helicobacter/efectos de los fármacos , Infecciones por Helicobacter/tratamiento farmacológico , Humanos , Huésped Inmunocomprometido , Inmunoglobulinas/uso terapéutico , Pierna , Masculino , Pruebas de Sensibilidad Microbiana , Insuficiencia del Tratamiento , Adulto Joven
8.
Pan Afr Med J ; 18: 199, 2014.
Artículo en Inglés | MEDLINE | ID: mdl-25419326

RESUMEN

The tropical diabetes hand syndrome is a complication affecting patients with diabetes mellitus in the tropics, and consists of localized cellulitis, swelling and ulceration of the hands which may progress to fulminant sepsis and gangrene of the whole limb. It is associated with a poor outcome. We report a 32 year old woman with tropical diabetes hand infection with autoamputation of the digits, review the relevant literature, and highlight the need for prevention and early hospital presentation in diabetics with hand infection, in order to prevent potentially crippling or fatal complications.


Asunto(s)
Celulitis (Flemón)/etiología , Complicaciones de la Diabetes/fisiopatología , Deformidades Adquiridas de la Mano/etiología , Infecciones por Klebsiella/complicaciones , Úlcera Cutánea/etiología , Adulto , Glucemia/análisis , Celulitis (Flemón)/microbiología , Complicaciones de la Diabetes/sangre , Diabetes Mellitus Tipo 2/complicaciones , Femenino , Humanos , Medicinas Tradicionales Africanas , Factor de Crecimiento Derivado de Plaquetas/uso terapéutico , Factores de Riesgo , Úlcera Cutánea/tratamiento farmacológico , Infección de Heridas/etiología
12.
Avian Dis ; 56(4): 659-69, 2012 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-23397836

RESUMEN

Antimicrobial/host defense peptides (A/HDP) are natural compounds that are found in leucocyte cells and on the skin and bodily fluids of birds, reptiles, and mammals. Not only do they possess antibacterial, antiviral, and antiparasitic characteristics but they also stimulate the host immune system to combat infectious diseases and may play a role in the promotion of wound repair. Gamma-amino butyric acid (GABA) is an amino acid-based inhibitory neurotransmitter in the brain that has also been shown to promote wound healing on skin. The objective of this study was to establish a therapeutic cocktail that protects birds against Escherichia coli-related disease and lesions in broilers. We injected a cocktail of six A/HDPs with or without GABA into 3-wk-old broilers by a subcutaneous or intramuscular route followed 24 hr later by challenge with a field isolate of serogroup O2 E. coli. Birds were examined for 5-6 days post-E. coli challenge and clinical, pathologic, and bacteriologic assessments were conducted. Birds that were subcutaneously injected with an A/HDP plus GABA cocktail had significantly higher survival rates and lower levels of bacteremia (P < 0.05), but a similar percentage of the surviving birds had large cellulitis lesions compared to the surviving phosphate-buffered saline-injected control birds. When this cocktail was administered intramuscularly, there was a trend towards protection against E. coli-related death, although the results were not statistically significant and there was no reduction in bacteremia. A significant number of birds had a reduced bacterial load on cellulitis lesions but no reduction in lesion size, which suggests that when the cocktail was administered intramuscularly it failed to protect against cellulitis. These results suggest that the route of administration of the cocktail influences disease outcome. Gene expression analysis was performed to investigate whether the cocktail induced immunomodulatory functions in avian cells that complemented their antimicrobial and anti-endotoxic effects. A/HDP plus GABA mediated temporal induction of pro-inflammatory cytokines but no induction of any of the chemokines under investigation. This cocktail shows potential to protect against E. coli-related death, which is a major economic burden to the poultry industry.


Asunto(s)
Péptidos Catiónicos Antimicrobianos/uso terapéutico , Bacteriemia/veterinaria , Celulitis (Flemón)/veterinaria , Pollos , Infecciones por Escherichia coli/veterinaria , Enfermedades de las Aves de Corral/prevención & control , Ácido gamma-Aminobutírico/uso terapéutico , Adyuvantes Inmunológicos/uso terapéutico , Factores de Edad , Animales , Péptidos Catiónicos Antimicrobianos/administración & dosificación , Péptidos Catiónicos Antimicrobianos/inmunología , Bacteriemia/microbiología , Bacteriemia/prevención & control , Celulitis (Flemón)/microbiología , Celulitis (Flemón)/prevención & control , Relación Dosis-Respuesta a Droga , Escherichia coli/efectos de los fármacos , Infecciones por Escherichia coli/microbiología , Infecciones por Escherichia coli/prevención & control , Regulación de la Expresión Génica , Inyecciones Intramusculares/veterinaria , Inyecciones Subcutáneas/veterinaria , Macrófagos/efectos de los fármacos , Macrófagos/inmunología , Enfermedades de las Aves de Corral/microbiología , Reacción en Cadena en Tiempo Real de la Polimerasa/veterinaria , Ácido gamma-Aminobutírico/administración & dosificación , Ácido gamma-Aminobutírico/inmunología
13.
J Infect Dev Ctries ; 4(8): 521-5, 2010 Sep 03.
Artículo en Inglés | MEDLINE | ID: mdl-20818105

RESUMEN

We report the first case of a post-acupuncture soft tissue infection due to Mycobacterium fortuitum. Two months after finishing an acupuncture treatment session, an immunocompetent 23-year-old woman developed cellulitis at the side of the needle insertions and the acid-fast bacillus was isolated from a closed abscess. The patient was successfully treated with a proper drug combination. We review the literature concerning the infection source and the risks for skin and soft tissue infection due to mycobacteria after acupuncture. The infection source in most cases is unknown but is probably associated with the inadequate sterilization of the needles or the puncture site. We show that these infections are not rare but difficult to diagnose. To avoid delays in the definitive diagnosis, infection with mycobacteria should be considered for skin and soft tissue infections, in particular late-onset infections, which are negative for routine bacterial cultures and without a clinical response to antibiotics used for acute pyogenic infections. Bacterial cultures from this lesion should be maintained for at least six weeks before discharged as negative.


Asunto(s)
Terapia por Acupuntura/efectos adversos , Celulitis (Flemón)/diagnóstico , Infecciones por Mycobacterium no Tuberculosas/diagnóstico , Mycobacterium fortuitum/aislamiento & purificación , Infecciones de los Tejidos Blandos/diagnóstico , Antibacterianos/uso terapéutico , Celulitis (Flemón)/tratamiento farmacológico , Celulitis (Flemón)/microbiología , Femenino , Humanos , Infecciones por Mycobacterium no Tuberculosas/tratamiento farmacológico , Infecciones por Mycobacterium no Tuberculosas/microbiología , Infecciones de los Tejidos Blandos/tratamiento farmacológico , Infecciones de los Tejidos Blandos/microbiología , Venezuela , Adulto Joven
14.
Pediatr Dermatol ; 24(3): 330-1, 2007.
Artículo en Inglés | MEDLINE | ID: mdl-17542898

RESUMEN

Infection of the eyelids confined to the preseptal space is relatively common but potentially serious. We report a child with cutaneous anthrax to remind that the interesting contagious cause be included in the differential diagnosis of the preseptal cellulitis.


Asunto(s)
Carbunco/diagnóstico , Celulitis (Flemón)/microbiología , Infecciones Bacterianas del Ojo/microbiología , Enfermedades Cutáneas Papuloescamosas/microbiología , Humanos , Lactante , Masculino , Medicina Tradicional
15.
Antimicrob Agents Chemother ; 51(7): 2628-30, 2007 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-17502411

RESUMEN

To evaluate empirical therapy with trimethoprim-sulfamethoxazole or doxycycline for outpatient skin and soft tissue infections in an area of high prevalence of methicillin-resistant Staphylococcus aureus, a randomized, prospective, open-label investigation was performed. The overall clinical failure rate was 9%, with all failures occurring in the trimethoprim-sulfamethoxazole group. However, there was no significant difference between the clinical failure rate of empirical trimethoprim-sulfamethoxazole therapy and that of doxycycline therapy.


Asunto(s)
Celulitis (Flemón)/epidemiología , Celulitis (Flemón)/microbiología , Investigación Empírica , Resistencia a la Meticilina/efectos de los fármacos , Infecciones Estafilocócicas/epidemiología , Infecciones Estafilocócicas/microbiología , Staphylococcus aureus/clasificación , Adolescente , Adulto , Anciano , Celulitis (Flemón)/tratamiento farmacológico , Doxiciclina/uso terapéutico , Quimioterapia Combinada , Estudios de Seguimiento , Humanos , Pruebas de Sensibilidad Microbiana , Persona de Mediana Edad , Pacientes Ambulatorios , Prevalencia , Estudios Prospectivos , Infecciones Estafilocócicas/tratamiento farmacológico , Staphylococcus aureus/efectos de los fármacos , Staphylococcus aureus/genética , Sulfametoxazol/uso terapéutico , Factores de Tiempo , Resultado del Tratamiento , Trimetoprim/uso terapéutico
16.
Antimicrob Agents Chemother ; 48(12): 4754-61, 2004 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-15561853

RESUMEN

WCK 771, the arginine salt of S-(-)-nadifloxacin, was evaluated in animal models of staphylococcal infection and in vitro. For 302 methicillin-susceptible strains the MIC at which 50% of isolates are inhibited (MIC50) and the MIC90 of WCK 771 were 0.03 and 0.03 microg/ml, respectively, and for 198 methicillin-resistant strains the MIC50 and the MIC90 were 0.5 and 1.0 microg/ml, respectively. All methicillin-susceptible staphylococci were quinolone susceptible, and almost all methicillin-resistant staphylococci were quinolone resistant. WCK 771 was more potent than moxifloxacin, trovafloxacin, levofloxacin, and ciprofloxacin and had potency comparable to that of clinafloxacin. Only WCK 771 and clinafloxacin demonstrated strong potencies against vancomycin-intermediate Staphylococcus aureus strains (MICs = 1 microg/ml). WCK 771 is not a substrate of the NorA pump, as evident from the lack of an effect of reserpine on the MICs and similar protective doses against infections caused by efflux-positive and -negative staphylococci. WCK 771 was effective by both the oral and the subcutaneous routes in mice infected intraperitoneally with quinolone-susceptible methicillin-susceptible S. aureus (MSSA) strains. For infections caused by quinolone-resistant methicillin-resistant S. aureus (MRSA) strains, the activity of WCK 771 administered subcutaneously was superior to those of trovafloxacin and sparfloxacin, with a 50% effective dose range of 27.8 to 46.8 mg/kg of body weight. The activity of WCK 771 was superior to those of moxifloxacin, vancomycin, and linezolid in a mouse cellulitis model of infection caused by one MSSA and two MRSA strains, with effective doses of 2.5 and 5 mg/kg for the MSSA strain and 10-fold higher effective doses for MRSA strains. WCK 771, like vancomycin and linezolid, eradicated MRSA from mouse liver, spleen, kidney, and lung when it was administered subcutaneously at a dose of 50 mg/kg for four doses. These studies have demonstrated the effectiveness of WCK 771, administered orally and parenterally, for the treatment of diverse staphylococcal infections in mice, including those caused by quinolone-resistant strains.


Asunto(s)
Antibacterianos/uso terapéutico , Fluoroquinolonas/uso terapéutico , Infecciones Estafilocócicas/tratamiento farmacológico , Administración Oral , Animales , Antibacterianos/farmacocinética , Antibacterianos/farmacología , Área Bajo la Curva , Proteínas Bacterianas/genética , Celulitis (Flemón)/tratamiento farmacológico , Celulitis (Flemón)/microbiología , Farmacorresistencia Bacteriana , Fluoroquinolonas/farmacocinética , Fluoroquinolonas/farmacología , Semivida , Inyecciones Subcutáneas , Resistencia a la Meticilina , Ratones , Pruebas de Sensibilidad Microbiana , Proteínas Asociadas a Resistencia a Múltiples Medicamentos , Quinolizinas/farmacocinética , Quinolizinas/farmacología , Quinolizinas/uso terapéutico , Sepsis/tratamiento farmacológico , Sepsis/microbiología , Infecciones Estafilocócicas/microbiología , Staphylococcus aureus/efectos de los fármacos , Staphylococcus aureus/genética
17.
J Surg Orthop Adv ; 13(2): 57-68, 2004.
Artículo en Inglés | MEDLINE | ID: mdl-15281401

RESUMEN

Necrotizing soft tissue infections encompass a wide variety of clinical syndromes resulting from introduction of various pathogens into injured or devitalized tissue. The extent of microbial involvement in such tissue may range from simple contamination to overt and progressive local tissue necrosis, which, if untreated, may lead to septicemia and death. Early differentiation among these infections is not always possible, as there are overlapping classification criteria. These infections exist along a continuum of clinical severity with different etiological agents and associated medical conditions. The often subtle clues heralding the presence of a necrotizing soft tissue infection must be sought so that expeditious surgical debridement and broad-spectrum antibiotic management are initiated. Although experience enables the clinician to make a specific diagnosis based on early findings, aggressive and proper treatment of suspected infections remains the priority. The purpose of the article is to provide an overview of necrotizing soft tissue infections in the upper extremity, focusing on gas gangrene, or clostridial myonecrosis, and necrotizing fasciitis, to facilitate early diagnosis and optimal management of these lethal diseases.


Asunto(s)
Fascitis Necrotizante/diagnóstico , Fascitis Necrotizante/terapia , Gangrena Gaseosa/diagnóstico , Gangrena Gaseosa/terapia , Infecciones de los Tejidos Blandos/microbiología , Extremidad Superior/microbiología , Celulitis (Flemón)/microbiología , Clostridium/fisiología , Fascitis Necrotizante/fisiopatología , Gangrena Gaseosa/fisiopatología , Humanos , Oxigenoterapia Hiperbárica
19.
J Pediatr Hematol Oncol ; 25(4): 324-6, 2003 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-12679649

RESUMEN

Children with acute lymphoblastic leukemia (ALL) are at risk for serious electrolyte abnormalities. The authors report their experience in managing a child with ALL who developed severe hyperphosphatemia as a consequence of a large exogenous load of phosphorus from high-dose liposomal amphotericin B. Health care providers need to recognize this potentially life-threatening complication of liposomal amphotericin B, since early detection and intervention can prevent significant morbidity.


Asunto(s)
Anfotericina B/efectos adversos , Antifúngicos/efectos adversos , Aspergilosis/tratamiento farmacológico , Candidiasis/tratamiento farmacológico , Celulitis (Flemón)/tratamiento farmacológico , Liposomas/efectos adversos , Mucormicosis/tratamiento farmacológico , Enfermedades Orbitales/tratamiento farmacológico , Fosfatos/sangre , Fosfatidilcolinas/efectos adversos , Fosfatidilgliceroles/efectos adversos , Leucemia-Linfoma Linfoblástico de Células Precursoras/tratamiento farmacológico , Sinusitis/tratamiento farmacológico , Anfotericina B/administración & dosificación , Antifúngicos/administración & dosificación , Aspergilosis/complicaciones , Carbonato de Calcio/uso terapéutico , Candidiasis/complicaciones , Celulitis (Flemón)/microbiología , Niño , Portadores de Fármacos/efectos adversos , Femenino , Cefalea/etiología , Humanos , Hiperparatiroidismo Secundario/etiología , Huésped Inmunocomprometido , Itraconazol/uso terapéutico , Liposomas/química , Mucormicosis/complicaciones , Enfermedades Orbitales/microbiología , Hormona Paratiroidea/sangre , Fosfatidilcolinas/administración & dosificación , Fosfatidilgliceroles/administración & dosificación , Recurrencia , Convulsiones/etiología , Sinusitis/microbiología , Vitamina D/sangre
20.
Ann Pharmacother ; 37(3): 392-4, 2003 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-12639170

RESUMEN

OBJECTIVE: To report a case of Pasteurella multocida cellulitis and bacteremia treated successfully with aztreonam. CASE SUMMARY: An 81-year-old white man with multiple antibiotic allergies was admitted with severe cellulitis of the left arm and bacteremia due to P. multocida. The patient was treated for 14 days with aztreonam and had complete resolution of the infection. DISCUSSION: To our knowledge, this is the first published case describing successful treatment of P. multocida cellulitis and bacteremia with aztreonam. Antimicrobials recommended for use in P. multocida infections include penicillin, ampicillin, amoxicillin, second- and third-generation cephalosporins, tetracyclines, fluoroquinolones, and trimethoprim/sulfamethoxazole. There is very little information in the current literature regarding the activity of aztreonam toward P. multocida. CONCLUSIONS: This case demonstrates the potential use of aztreonam for P. multocida cellulitis and bacteremia in those instances where antibiotics of choice cannot be given.


Asunto(s)
Antibacterianos/uso terapéutico , Aztreonam/uso terapéutico , Bacteriemia/tratamiento farmacológico , Gatos , Celulitis (Flemón)/tratamiento farmacológico , Infecciones por Pasteurella/tratamiento farmacológico , Pasteurella multocida/aislamiento & purificación , Anciano , Anciano de 80 o más Años , Animales , Antibacterianos/farmacología , Aztreonam/farmacología , Bacteriemia/microbiología , Mordeduras y Picaduras , Celulitis (Flemón)/microbiología , Humanos , Masculino , Pruebas de Sensibilidad Microbiana , Infecciones por Pasteurella/microbiología , Pasteurella multocida/efectos de los fármacos
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA